|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Herpes labialis |
|
Infection, herpes simplex |
| |
|
|
SIDE EFFECTS:
|
|
Application site reaction |
|
Headache |
|
Hypoesthesia |
|
skin rash, erythematous |
|
taste perversion |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Antiviral-
Topical, to cold sores every two hours during waking hours for four days. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Antiviral-
Topical, to cold sores every two hours during waking hours for four days. |
|
|
|
|